Aurobindo Pharma Limited (AUROPHARMA.NS) Stock Price, News & Chart

	AUROPHARMA.NS	AJANTPHARM.NS	IPCALAB.NS	APLLTD.NS	SUNPHARMA.NS	000739.SZ
Market cap	1.03T	410.13B	494.62B	175.63B	4.39T	25.56B
P/E (TTM)	25.9	32.5	37.8	20.8	40.0	31.5
Forward P/E	19.0	27.9	27.7	18.2	29.0	21.4
Price/book	2.6	8.4	6.1	3.0	4.9	3.9
Dividend yield	—	1.93%	0.30%	1.32%	0.90%	1.75%
1-year change	+49.48%	+29.11%	+51.13%	−0.94%	+5.19%	+43.01%
Today	+4.69%	−1.04%	−1.14%	−1.46%	+3.14%	+2.22%

Market cap

1.03T

410.13B

494.62B

175.63B

4.39T

25.56B

P/E (TTM)

25.9

32.5

37.8

20.8

40.0

31.5

Forward P/E

19.0

27.9

27.7

18.2

29.0

21.4

Price/book

2.6

8.4

6.1

3.0

4.9

3.9

Dividend yield

—

1.93%

0.30%

1.32%

0.90%

1.75%

1-year change

+49.48%

+29.11%

+51.13%

−0.94%

+5.19%

+43.01%

Today

+4.69%

−1.04%

−1.14%

−1.46%

+3.14%

+2.22%

Company	Mkt cap	Price	Today
Ajanta Pharma LimitedAJANTPHARM.NS · Drug Manufacturers - Specialty & Generic	410.13B	3,282.10	−1.04%
Ipca Laboratories LimitedIPCALAB.NS · Drug Manufacturers - Specialty & Generic	494.62B	1,949.60	−1.14%
Alembic Pharmaceuticals LimitedAPLLTD.NS · Drug Manufacturers - Specialty & Generic	175.63B	893.50	−1.46%
Sun Pharmaceutical Industries LimitedSUNPHARMA.NS · Drug Manufacturers - Specialty & Generic	4.39T	1,829.00	+3.14%
Apeloa Pharmaceutical Co.,Ltd000739.SZ · Drug Manufacturers - Specialty & Generic	25.56B	22.06	+2.22%
Teva Pharmaceutical Industries LimitedTEVA · Drug Manufacturers - Specialty & Generic	47.93B	41.08	−1.78%
Auro Laboratories LimitedAUROLAB.BO · Drug Manufacturers - Specialty & Generic	1.40B	224.80	−1.01%
The United Laboratories International Holdings Limited3933.HK · Drug Manufacturers - Specialty & Generic	15.37B	7.800	+6.41%

Company	Mkt cap	Price	Today
HK inno.N Corporation195940.KQ · Cheongju-si, South Korea	1.04T	36,650.00	+7.01%
Lupin LimitedLUPIN.NS · Mumbai, India	909.09B	1,988.00	−1.03%
Mankind Pharma LimitedMANKIND.BO · New Delhi, India	1.04T	2,515.00	−0.72%
Sumitomo Pharma Co., Ltd.4506.T · Osaka, Japan	932.63B	2,079.00	+7.53%
Cipla LimitedCIPLA.BO · Mumbai, India	1.13T	1,401.75	+0.12%
Dr. Reddy's Laboratories LimitedDRREDDY.NS · Hyderabad, India	1.14T	1,366.00	−0.58%
Daewoong Pharmaceutical Co., Ltd069620.KS · Seoul, South Korea	1.23T	106,700.00	+3.69%
Zydus Lifesciences LimitedZYDUSLIFE.NS · Ahmedabad, India	1.19T	1,193.00	+0.41%

Company	Mkt cap	Price	Today
Ingenia Therapeutics Inc.950260.KQ · Biotechnology	993.73B	20,100.00	+2.97%
HK inno.N Corporation195940.KQ · Drug Manufacturers - Specialty & Generic	1.04T	36,650.00	+7.01%
Asahi Intecc Co., Ltd.7747.T · Medical Instruments & Supplies	1.03T	3,890.00	+7.97%
Pfizer Inc.PFIZ34.SA · Drug Manufacturers - General	948.00B	41.58	+0.32%
Abbott LaboratoriesABTT34.SA · Medical Devices	1.09T	52.45	0.00%
Sphere Corp.347700.KQ · Health Information Services	763.29B	15,360.00	−13.56%
Bayer AktiengesellschaftBAYNN.MX · Drug Manufacturers - General	936.33B	953.08	0.00%
Lupin LimitedLUPIN.NS · Drug Manufacturers - Specialty & Generic	909.09B	1,988.00	−1.03%

Company	Mkt cap	Price	Today
Divi's Laboratories LimitedDIVISLAB.BO · Hyderabad, India	2.69T	10,150.00	+1.14%
Laurus Labs LimitedLAURUSLABS.NS · Hyderabad, India	1.27T	2,346.00	+0.96%
Dr. Reddy's Laboratories LimitedDRREDDY.BO · Hyderabad, India	1.13T	1,360.80	−0.82%
NMDC LimitedNMDC.BO · Hyderabad, India	619.65B	70.48	+0.86%
Gland Pharma LimitedGLAND.NS · Hyderabad, India	518.99B	3,145.20	−0.44%
Premier Energies LimitedPREMIERENE.NS · Hyderabad, India	398.50B	882.50	−2.38%
Bharat Dynamics LimitedBDL.BO · Hyderabad, India	394.42B	1,076.00	−0.09%
Sai Life Sciences LimitedSAILIFE.NS · Hyderabad, India	338.79B	1,594.50	+3.13%

Company	Mkt cap	Price	Today
Glenmark Pharmaceuticals LimitedGLENMARK.BO · life sciences	701.47B	2,485.50	−0.65%
Ipca Laboratories LimitedIPCALAB.NS · life sciences	494.62B	1,949.60	−1.14%
Alembic Pharmaceuticals LimitedAPLLTD.NS · life sciences	175.63B	893.50	−1.46%
Takeda Pharmaceutical Company Limited4502.T · life sciences	11.00T	6,888.00	+4.55%
RPG Life Sciences LimitedRPGLIFE.NS · life sciences	42.93B	2,595.70	−0.11%
Evonile Pharma LimitedNOVARTIND.BO · life sciences	42.46B	1,719.85	+0.09%
Daewoong Pharmaceutical Co., Ltd069620.KS · life sciences	1.23T	106,700.00	+3.69%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd1276.HK · life sciences	350.78B	52.850	+2.32%

Company	Mkt cap	Price	Today
Glenmark Pharmaceuticals LimitedGLENMARK.NS · Correlation 0.43	700.43B	2,481.80	−0.91%
Laurus Labs LimitedLAURUSLABS.NS · Correlation 0.42	1.27T	2,346.00	+0.96%
Laurus Labs LimitedLAURUSLABS.BO · Correlation 0.42	1.27T	2,345.00	+1.69%
Lupin LimitedLUPIN.NS · Correlation 0.40	909.09B	1,988.00	−1.03%
Glenmark Pharmaceuticals LimitedGLENMARK.BO · Correlation 0.40	701.47B	2,485.50	−0.65%
Zydus Lifesciences LimitedZYDUSLIFE.NS · Correlation 0.38	1.19T	1,193.00	+0.41%
Mankind Pharma LimitedMANKIND.BO · Correlation 0.38	1.04T	2,515.00	−0.72%
Biocon LimitedBIOCON.NS · Correlation 0.36	592.87B	362.00	+5.10%

Company	Mkt cap	Price	Today
LUPIN LIMITEDLUPIN.NS	909.09B	1,988.00	−1.03%
GLENMARK PHARMACEUTICALSGLENMARK.NS	700.43B	2,481.80	−0.91%
BIOCON LIMITED.BIOCON.NS	592.87B	362.00	+5.10%
SUN PHARMACEUTICAL IND LSUNPHARMA.NS	4.39T	1,829.00	+3.14%
DIVI S LABORATORIES LTDDIVISLAB.NS	2.69T	10,140.50	+1.03%

Moneycontrol·21h agoPositive

Aurobindo Pharma Q2: Net profit rises 32.5% to Rs 1,124 crore, revenue hits record high

Aurobindo Pharma reported its highest-ever quarterly revenue in the September quarter, with consolidated net profit rising 32.5% year-on-year to Rs 1,124 crore, as strong growth in the US and European markets, new product launches and…

BusinessLine·22h agoPositive

Q2 Results Today Highlights: BSE, Sundaram Finance, Dabur, Nykaa, Lenskart, Alembic Pharma, Aurobindo Pharma, HUDCO, Apollo Hospitals, NHPC Q2 profit rises, Biocon, Zydus Life profit declines

Follow our stock market live updates here | Stay tuned to businessline for more. FSN E-Commerce Ventures (Nykaa): 36% increase in standalone PAT to ₹16.71 cr Lenskart Solutions: Standalone PAT rises 69.3% to ₹167.85 crore in Q2FY27…

BusinessLine·23h agoPositive

Aurobindo Pharma’s Q2 FY27 net up 32% at ₹1124 cr

K Nithyananda Reddy, Vice Chairman and Managing Director, Aurobindo Pharma Aurobindo Phama’s consolidated net profit increased 32.5 per cent at ₹1,124 crore in the second quarter of the current financial year ended September 30, 2026,…

CNBCTV18·20h agoPositive

Earnings Central: Lenskart, Nykaa, Aurobindo Pharma shine; PI Industries, Apollo Tyres face margin heat

Alembic Pharmaceuticals led the day's movers. Revenue rose 36.3% to ₹2,603 crore and profit after tax surged 81.1% to ₹335 crore, with US formulations revenue jumping 77% to ₹1,003 crore after three product launches during the quarter.…

News18·22h agoPositive

Aurobindo Pharma posts 32.5 pc rise in Q2 net profit on record revenue

New Delhi, Nov 4 (PTI) Aurobindo Pharma Ltd on Wednesday reported a 32.5 per cent increase in net profit to Rs 1,123.84 crore during the September quarter, driven by growth across key businesses. The pharma major had posted a profit after…

AZN

Stevens Point·22h agoPositive

India’s Aurobindo Pharma’s quarterly profit rises by a third on strong US demand

Nov 4 (Reuters) – Indian drugmaker Aurobindo Pharma reported a nearly 33% rise in second-quarter profit ‌on Wednesday, led by strong demand and volume gains in its US market. • ‌Consolidated profit after ⁠tax rose to ⁠11.26 billion…

AGM AZN

BusinessLine·1d agoPositive

Q2 Results 04th Nov Live: BSE, Cummins, Zydus Lifesciences, Apollo, Lenskart, Nykaa, Aurobindo Pharma, NHPC, Dabur, Torrent Power, Biocon, Sundaram Finance, Premier Energies, Physicswallah Share to announce Q2 results, Bajaj Finserv, SBI, NSE, Lupin shares in focus

Follow our stock market live updates here | Stay tuned to businessline for more. GAINERS: SBI, Emcure Pharma, Awfis Space Sensex gained 214.75 pts or 0.28% to 77,132.60 at 9.16 am after opening at 76,853.11 from 76,917.85 previous close.…

TradingView·20h agoPositive

Aurobindo Pharma Q2 profit rises 33%, beats estimates; declares ₹7 interim dividend

Aurobindo Pharma reported a 32.8% year-on-year increase in consolidated net profit to ₹1,126 crore for the second quarter of FY27, compared with ₹848 crore in the corresponding quarter last year. The pharmaceutical company also reported…

MarketScreener·1d agoPositive

Aurobindo Pharma Expands Margins as Sales Grow

The real test for Aurobindo Pharma Ltd is turning ambition into steady earnings. Published on 08/12/2026 at 06:20 am EDT - Modified on 08/12/2026 at 08:16 am EDT India’s policies are pushing hard to strengthen domestic pharmaceutical…

MRK SPCX BMY AZN

MarketScreener·1d ago·2 outletsPositive

Aurobindo Pharma Limited Receives USFDA Final Approval For Perampanel Tablets, 2 Mg, 4 Mg, 6 Mg, 8 Mg, 10 Mg, And 12 Mg

Aurobindo Pharma Limited announced the receipt of final approval from the US Food & Drug Administration to manufacture and market Perampanel Tablets, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg, which... Aurobindo Pharma Limited announced the…

Install

Aurobindo Pharma Limited

Key statistics

Against its peers

Latest news